Posts in category: News

Advancing Evidence-Based Management of Pediatric Iron Deficiency Anemia in Kirkuk.

Event Date: August 9, 2026
Start Time: 9:00 AM
Venue: Azadi Teaching Hospital – Dr. Najmaddin Barzanjy’s Hall
Location: Kirkuk, Iraq

XenoFarma Pharmaceuticals successfully organized a specialized Scientific Round Table Discussion (RTD) on August 9, 2026, at Azadi Teaching Hospital in Kirkuk, bringing together pediatric specialists for an interactive scientific exchange focused on the diagnosis and management of anemia in children.

The scientific program featured two complementary presentations addressing both the clinical evaluation of pediatric anemia and contemporary approaches to oral iron delivery.

Approach to Anemia in Children

Dr. Amal Adnan Rashed, Consultant Pediatrician, delivered a comprehensive presentation addressing the clinical approach to anemia in pediatric patients. The session reviewed important considerations in patient assessment, diagnostic evaluation, differential diagnosis, and evidence-based management, emphasizing the importance of identifying the underlying cause of anemia before selecting an appropriate therapeutic strategy.

Advanced Elemental Iron Delivery in Pediatric Iron Deficiency Anemia

The second presentation, delivered by Dr. Rawand Sirwan Izzalddin, Product and Business Development Manager at XenoFarma, focused on:

“Advanced Elemental Iron Delivery: Utilizing Micro-Particulate Carbonyl Iron Suspension (Innofer® Suspension) in the Management of Pediatric Iron Deficiency Anemia.”

The session explored the characteristics of micro-particulate carbonyl iron and discussed the formulation, tolerability, bioavailability, and practical considerations associated with Innofer® Suspension in the management of pediatric iron deficiency anemia.

The round table format encouraged active participation from attending pediatric specialists, providing an opportunity to discuss clinical experiences, practical treatment considerations, and challenges encountered in the management of iron deficiency anemia in children.

Through educational activities such as this, XenoFarma continues to support continuous medical education, evidence-based clinical practice, and meaningful scientific collaboration with healthcare professionals across Iraq.

Event Date: August 3, 2026
Start Time: 9:00 AM
Venue: Hawler Teaching Hospital
City: Erbil, Iraq

As part of the Kurdistan Board Internal Medicine Weekly Medical Meeting, XenoFarma participated in a scientific seminar held on August 3, 2026, at Hawler Teaching Hospital in Erbil, bringing together internal medicine specialists and physicians for an educational session focused on common clinical challenges encountered in everyday practice.

The seminar explored contemporary, evidence-based approaches to the management of iron deficiency, glycemic control, and functional digestive disorders, emphasizing practical strategies that support patient-centered care.

Ph. Rawand Sirwan, M.Sc. in Pharmaceutical Technology, presented modern therapeutic approaches for the management of iron deficiency and optimization of glycemic control, discussing treatment selection, patient tolerability, and practical considerations for improving long-term clinical outcomes.

Ph. Dyar Mudhafar, M.Sc. in Clinical Pharmacy, delivered a presentation on the multimodal management of functional dyspepsia and postprandial digestive symptoms, highlighting the importance of supporting digestive function, maintaining gastrointestinal comfort, and preserving microbiota balance as part of comprehensive patient care.

The seminar promoted active scientific discussion and knowledge exchange, enabling participants to connect current evidence with routine clinical practice and strengthen informed clinical decision-making. A complimentary coffee break followed the educational program, providing additional opportunities for professional networking and discussion.

Through its continued support of educational initiatives, XenoFarma remains committed to advancing evidence-based medicine and strengthening collaboration with healthcare professionals across Iraq.

Event Date: July 28, 2026
Start Time: 9:00 AM
Venue: Qasir Al-Sultan Restaurant
City: Mosul, Iraq

On July 28, 2026, XenoFarma successfully organized an exclusive scientific meeting at Qasir Al-Sultan Restaurant in Mosul, bringing together a distinguished group of General Surgeons to explore emerging innovations in wound management and post-operative care.

The scientific session focused on advanced drug delivery strategies designed to improve wound healing outcomes and support infection prevention. Particular attention was given to an innovative combination of micronized silver with sodium hyaluronate, highlighting its role in providing antimicrobial protection while promoting tissue regeneration and an optimal wound-healing environment.

Participants discussed the importance of modern wound care technologies in enhancing post-operative recovery, reducing the risk of surgical site infections, and supporting effective tissue repair. The meeting also reviewed current concepts in biocompatible wound management and their practical application in routine surgical practice.

The interactive format encouraged surgeons to exchange clinical experiences, discuss challenging cases, and evaluate evidence-based approaches that can improve patient outcomes.

Through scientific meetings such as this, XenoFarma continues to support continuous medical education and strengthen collaboration with healthcare professionals by introducing innovative, evidence-based solutions for modern surgical care.

Event Date: July 25, 2026
Start Time: 12:30 PM
Venue: Lezzet Restaurant
Location: Erbil, Iraq

XenoFarma successfully organized a scientific Round Table Discussion on July 25, 2026, bringing together a distinguished group of gynecologists in Erbil to discuss evidence-based approaches for advancing women’s health and reproductive care.

The meeting focused on contemporary strategies for the management of female subfertility, vulvovaginal lesions, and restoration of the vaginal mucosal ecosystem, highlighting innovative therapeutic options designed to improve clinical outcomes and patient quality of life.

The scientific program featured discussions on three key therapeutic solutions:

• Ginfast FRT®, presented as an evidence-based option to support hormonal balance, ovulation, and oocyte quality in women undergoing subfertility management.
• Silver Care® Spray & Cream, an advanced silver-ion formulation designed to provide antimicrobial protection while supporting tissue repair and post-procedural healing in vulvovaginal lesions.
• Fluginol®, a targeted non-hormonal formulation developed to help restore vaginal pH, relieve mucosal dryness, and reduce irritation, thereby supporting vaginal health and comfort.

The round table encouraged active participation and scientific dialogue, enabling attendees to exchange clinical experiences and discuss practical applications of these therapeutic approaches in routine gynecological practice.

Through educational initiatives such as this, XenoFarma continues to support continuous medical education and strengthen collaboration with healthcare professionals by promoting innovative, evidence-based solutions that contribute to improved women’s health.

Event Date: July 23, 2026
Start Time: 1:00 PM
Venue: Lezzet Restaurant
Location: Iraq

XenoFarma successfully organized a Scientific Meeting for Family Medicine Specialists on July 23, 2026, reaffirming its commitment to supporting evidence-based medical education and fostering meaningful scientific collaboration among healthcare professionals.

The meeting brought together family medicine physicians for an engaging educational program featuring three scientific sessions that addressed important topics in primary healthcare and preventive medicine.

Scientific Program

1. Geriatric Health
Presented by: Dr. Amer A. Dhiab, Consultant Physician in Family Medicine (MBChB, FICMS/FM)

The session explored contemporary approaches to healthy aging, emphasizing comprehensive assessment, preventive strategies, and patient-centered management of common health conditions affecting older adults.

2. Novel Phytotherapeutic Management for Pediatric Renal and Urinary Tract Disorders
Presented by: Ph. Rawand Sirwan Izzalddin, B.Sc., M.Sc. in Pharmaceutical Technology

This presentation reviewed emerging evidence supporting phytotherapeutic interventions in pediatric renal and urinary tract disorders, highlighting their role as supportive therapeutic options within evidence-based clinical practice.

3. Effects of Probiotics on Gut Microbiota: An Overview
Presented by: Ph. Dyar Mudhafar Salman, B.Sc., M.Sc. in Clinical Pharmacy

The final session discussed the strain-specific effects of probiotics on gut microbiota, examining their contribution to maintaining gastrointestinal health and their potential role in supporting overall patient well-being.

The meeting concluded with an interactive scientific discussion, providing participants with an opportunity to exchange clinical experiences and explore practical applications of current evidence in family medicine.

XenoFarma remains dedicated to strengthening partnerships with healthcare professionals and supporting high-quality educational initiatives that contribute to improved clinical practice and better patient care.

Our focus is our strength.

Event Date: July 21, 2026
Start Time: 12:30 PM
Venue: Hardi Restaurant
Location: Halabja, Sulaymaniyah, Iraq

On July 21, 2026, XenoFarma successfully organized a specialized scientific meeting at Hardi Restaurant in Halabja, bringing together a distinguished group of internists, endocrinologists, and gynecologists to discuss contemporary approaches to the management of Type 2 Diabetes Mellitus.

The scientific session focused on the challenges of glycemic control, with particular emphasis on postprandial hyperglycemia and its role in the long-term progression of diabetes and its complications. Participants reviewed current evidence on the importance of controlling postprandial glucose excursions as part of a comprehensive diabetes management strategy.

A key topic of the meeting was “A Novel Approach to Postprandial Glycemic Management: The Role of Reversible α-Glucosidase Inhibition in Controlling Glycemic Spikes.” The discussion explored the physiological basis of reversible α-glucosidase inhibition and its contribution to reducing postprandial glucose fluctuations while supporting overall metabolic control.

The session also highlighted the clinical role of Glicoper D®, an Italian phytotherapeutic product from Erbozeta, as a safe and effective option for supporting Type 2 Diabetes Mellitus management and improving postprandial glycemic control. Participants engaged in an interactive scientific discussion, exchanging clinical experiences and practical perspectives on integrating evidence-based phytotherapy into routine diabetes care.

Through such educational initiatives, XenoFarma continues to promote continuous medical education and support healthcare professionals with innovative, evidence-based therapeutic solutions.

Event Date: July 18, 2026

XenoFarma successfully organized a specialized scientific meeting on July 18, 2026, bringing together a distinguished group of radiotherapists to discuss important gastrointestinal considerations encountered during radiotherapy treatment.

The session focused on evidence-based approaches to optimizing gastrointestinal care before and during radiotherapy. Particular attention was given to the clinical role of PURGOTEC® in bowel preparation and rectal evacuation, especially in patients undergoing prostate radiotherapy, where appropriate bowel management contributes to treatment accuracy and patient comfort.

The meeting also highlighted the benefits of TRIO-ZYME® in the management of common gastrointestinal symptoms, including dyspepsia, bloating, indigestion, and occasional acidity. The discussion reviewed practical considerations for supporting digestive health and improving patient comfort throughout the course of treatment.

The session encouraged active scientific discussion and exchange of clinical experience among participants, providing an opportunity to review practical strategies that can be incorporated into routine radiotherapy practice.

XenoFarma remains committed to supporting continuous medical education and advancing multidisciplinary collaboration through scientific meetings that promote evidence-based patient care and improved clinical outcomes.

Event Date: June 29, 2026
Start Time: 9:00 AM
Venue: Emergency Hospital for Trauma and Burn
City: Erbil, Iraq

A specialized Round Table Discussion titled “Advanced Drug Delivery in Wound Management & Neuro-Regenerative Protocols” was successfully held on June 29, 2026, at the Emergency Hospital for Trauma and Burn in Erbil. The meeting brought together clinicians working in emergency, trauma, and burn care to discuss emerging innovations in the management of complex injuries.

The scientific session focused on the evolving role of Advanced Drug Delivery Systems (ADDS) in wound management, highlighting modern approaches designed to improve targeted drug delivery, support tissue repair, and optimize post-traumatic recovery. Participants also explored the growing field of neuro-regenerative protocols, reviewing current concepts and their potential contribution to improving functional recovery following traumatic injuries.

The interactive round table encouraged scientific dialogue and the exchange of clinical experience, allowing participants to discuss practical applications of these emerging technologies in emergency medicine and trauma care.

XenoFarma remains committed to supporting continuous medical education by facilitating high-quality scientific meetings that promote innovation, evidence-based practice, and multidisciplinary collaboration across Iraq.

On June 4, 2026, XenoFarma organized an exclusive scientific meeting at Geverke Restaurant in Duhok, bringing together a distinguished group of General Surgeons to discuss emerging innovations in wound management and post-operative care.

The scientific session, titled “Advanced and Novel Drug Delivery in the Management of Wounds,” focused on modern therapeutic approaches designed to enhance wound healing outcomes and support effective infection control. Particular attention was given to innovative drug delivery technologies that optimize local therapeutic action while promoting tissue repair and recovery.

During the meeting, participants explored a patented biocompatible approach to enhanced wound healing and antimicrobial protection, highlighting its potential role in supporting post-operative recovery, reducing infection risks, and improving overall wound management strategies. The discussion also reviewed key aspects of the wound healing process and the importance of integrating advanced technologies into contemporary surgical practice.

The event provided an interactive platform for scientific exchange, allowing surgeons to discuss clinical experiences, share practical insights, and evaluate emerging solutions that may contribute to improved patient outcomes.

Through such educational initiatives, XenoFarma continues to support continuous medical education and the advancement of evidence-based surgical care across Iraq.

Event Date: June 4, 2026
Start Time: 12:27 PM
Venue: Geverke Restaurant
City: Duhok, Iraq

A multidisciplinary scientific round table was successfully held on February 1, 2026, in Ranyah, bringing together physicians from multiple specialties, including General Practitioners, Gynecologists, and General Surgeons. The event provided a dynamic platform for scientific exchange and practical clinical discussion focused on updated, evidence-based approaches in daily medical practice.

The session highlighted the clinical value of Golaprop as a novel mucoadhesive approach for upper respiratory tract infections (URTIs). The discussion emphasized how enhanced mucosal adhesion and localized action contribute to effective symptom control and improved patient comfort, particularly in common upper respiratory conditions.

In addition, the round table addressed the role of Rinisona in the management of adenoidal hypertrophy, with emphasis on its benefits in reducing nasal obstruction, improving breathing quality, and enhancing overall quality of life. The discussion focused particularly on mild to moderate clinical cases, where conservative and targeted management plays a critical role.

The session was highly interactive, featuring active participation, case-based discussion, and extended Q&A, followed by individual scientific exchanges that allowed deeper clarification of clinical scenarios.

Through such focused educational initiatives, XenoFarma continues to support practical, evidence-driven medical education and multidisciplinary collaboration, reinforcing its commitment to advancing patient care across Iraq.

Event Date: February 1, 2026
Start Time: 12:00 PM
Venue: Chestamala Restaurant
City: Ranyah, Iraq